Wounding with a microneedling device corrects the inappropriate ultraviolet B radiation response in geriatric skin

Arch Dermatol Res. 2020 Jan;312(1):1-4. doi: 10.1007/s00403-019-02001-z. Epub 2019 Oct 28.

Abstract

Non-melanoma skin cancer primarily affects geriatric patients as evidenced by the fact that only 20% of these cancers are diagnosed in patients under the age of 60 years. Of importance, geriatric skin responds to procarcinogenic ultraviolet B radiation (UVB) in a manner that permits the establishment of tumor cells. Recent studies have indicated that wounding of geriatric skin with fractionated resurfacing lasers and dermabrasion upregulates fibroblast production of insulin-like growth factor-1 (IGF-1) and normalizes the procarcinogenic acute UVB response consisting of basal keratinocytes proliferating while still harboring unrepaired DNA damage. The present studies tested the ability of wounding with a commercially available microneedling device to upregulate IGF-1 levels and normalize the geriatric UVB response. Geriatric volunteers were treated with a microneedling device on buttock skin and 3 months later the IGF-1 levels and UVB responses tested in wounded vs control skin. Wounding via microneedling upregulated IGF-1 and resulted in lower levels of basal keratinocytes proliferating with unrepaired DNA damage. The ability of microneedling to protect against the formation of UVB-damaged proliferating keratinocytes indicates the potential of this wounding modality to reduce aging-associated non-melanoma skin cancer.

Keywords: Insulin-like growth factor-1; Ultraviolet B radiation; Wounding.

MeSH terms

  • Aged
  • Aging*
  • Cellular Senescence
  • Female
  • Humans
  • Insulin-Like Growth Factor I / genetics
  • Insulin-Like Growth Factor I / metabolism
  • Keratinocytes / physiology
  • Male
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Skin / radiation effects*
  • Ultraviolet Rays*

Substances

  • IGF1 protein, human
  • RNA, Messenger
  • Insulin-Like Growth Factor I